Results 171 to 180 of about 4,421 (195)

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation

Diabetes and Metabolism, 2019
David R Owens, Carmine Giuseppe Fanelli, Geremia B Bolli   +2 more
exaly  

Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes*

Journal of Diabetes, 2016
Gregory R Fulcher, Søren Rasmussen, Jens Sandahl Christiansen   +2 more
exaly  

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes

Diabetology International, 2014
Yuji Tajiri, Hitomi Nakayama, Ichiro Tokubuchi   +2 more
exaly  

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine

Expert Opinion on Drug Metabolism and Toxicology, 2015
Tim Heise, Leszek Nosek, Hanne Haahr
exaly  

Insulin degludec

2017
openaire   +1 more source

Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)

Diabetes Care, 2014
Tina Vilsbøll, Helena W Rodbard, John Buse   +2 more
exaly  

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

Diabetes Therapy, 2013
Tomoyuki Katsuno, Yoshiki Kusunoki, Jun-Ichiro Miyagawa   +2 more
exaly  

Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across Studies

Journal of Diabetes Science and Technology, 2018
Tim Heise
exaly  

Zulassungserweiterung von Insulin degludec

MMW - Fortschritte der Medizin, 2015
openaire   +1 more source

Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)

Journal of Diabetes Science and Technology, 2019
Lawrence A Leiter, Athena Philis-Tsimikas, Irene M. Stratton   +2 more
exaly